Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
View in:
PubMed
subject areas
Antineoplastic Agents
Apoptosis
Cell Differentiation
Cell Division
Chromans
Dose-Response Relationship, Drug
Drug Synergism
Gene Expression Regulation, Neoplastic
HT29 Cells
Humans
Osteosarcoma
Receptors, Cytoplasmic and Nuclear
Receptors, Retinoic Acid
Retinoid X Receptors
RNA, Neoplasm
Thiazoles
Thiazolidinediones
Time Factors
Transcription Factors
Tretinoin
Tumor Cells, Cultured
authors with profiles
Michael A. Simon
Rex C. Haydon
Tong-Chuan He
Terrance Peabody